These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4213339)

  • 1. Quinazolines as inhibitors of dihydrofolate reductase. 2.
    Hynes JB; Ashton WT
    J Med Chem; 1974 Sep; 17(9):1023-5. PubMed ID: 4213339
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of mammalian dihydrofolate reductase by selected 2,4-diaminiquinazolines and related compounds.
    Richter WE; McCormack JJ
    J Med Chem; 1974 Sep; 17(9):943-7. PubMed ID: 4213189
    [No Abstract]   [Full Text] [Related]  

  • 3. Quinazolines as inhibitors of dihydrofolate reductase. 3. Analogs of pteroic and isopteroic acids.
    Hynes JB; Buck JM; D'Souza L; Freisheim JH
    J Med Chem; 1975 Dec; 18(12):1191-4. PubMed ID: 811798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of dihydrofolate reductase. Structure-activity correlations of quinazolines.
    Fukunaga JY; Hansch C; Steller EE
    J Med Chem; 1976 May; 19(5):605-11. PubMed ID: 1271401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinazolines as inhibitors of dihydrofolate reductase. 1.
    Ashton WT; Walker FC; Hynes JB
    J Med Chem; 1973 Jun; 16(6):694-7. PubMed ID: 4715004
    [No Abstract]   [Full Text] [Related]  

  • 6. Quinazolines as inhibitors of dihydrofolate reductase. 4. Classical analogues of folic and isofolic acids.
    Hynes JB; Eason DE; Garrett CM; Colvin PL
    J Med Chem; 1977 Apr; 20(4):588-91. PubMed ID: 850245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined distance geometry analysis of dihydrofolate reductase inhibition by quinazolines and triazines.
    Ghose AK; Crippen GM
    J Med Chem; 1983 Jul; 26(7):996-1010. PubMed ID: 6864738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2,4-Diamino-5-substituted-quinazolines as inhibitors of a human dihydrofolate reductase with a site-directed mutation at position 22 and of the dihydrofolate reductases from Pneumocystis carinii and Toxoplasma gondii.
    Rosowsky A; Mota CE; Queener SF; Waltham M; Ercikan-Abali E; Bertino JR
    J Med Chem; 1995 Mar; 38(5):745-52. PubMed ID: 7877140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-amino-4-hydroxyquinazolines as inhibitors of thymidylate synthetase.
    Bird OD; Vaitkus JW; Clarke J
    Mol Pharmacol; 1970 Sep; 6(5):573-5. PubMed ID: 4990047
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of dihydrofolate reductase: structure-activity correlations of quinazolines based upon molecular shape analysis.
    Battershell C; Malhotra D; Hopfinger AJ
    J Med Chem; 1981 Jul; 24(7):812-8. PubMed ID: 7277385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folate antagonists. 9. 2,4-Diamino-6-((aralkyl)alkylamino)quinazolines, a potent class of antimetabolites with prodigious antimalarial effects.
    Elslager EF; Bird OD; Clarke J; Perricone SC; Worth DF
    J Med Chem; 1972 Nov; 15(11):1138-46. PubMed ID: 4631920
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitative structure-activity relationship by distance geometry: quinazolines as dihydrofolate reductase inhibitors.
    Ghose AK; Crippen GM
    J Med Chem; 1982 Aug; 25(8):892-9. PubMed ID: 7120278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of quinazoline analogs of isofolic acid.
    Hynes JB; Garrett CM
    J Med Chem; 1975 Jun; 18(6):632-4. PubMed ID: 1151982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of some bis(2,4-diaminopyrimidines) and bis(2,4-diaminoquinazolines) as potential antimalarial agents.
    Hynes JB; Gratz RF; Ashton WT
    J Med Chem; 1972 Dec; 15(12):1332-3. PubMed ID: 4629015
    [No Abstract]   [Full Text] [Related]  

  • 15. High-affinity inhibitors of dihydrofolate reductase: antimicrobial and anticancer activities of 7,8-dialkyl-1,3-diaminopyrrolo[3,2-f]quinazolines with small molecular size.
    Kuyper LF; Baccanari DP; Jones ML; Hunter RN; Tansik RL; Joyner SS; Boytos CM; Rudolph SK; Knick V; Wilson HR; Caddell JM; Friedman HS; Comley JC; Stables JN
    J Med Chem; 1996 Feb; 39(4):892-903. PubMed ID: 8632413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of 5-substituted quinazolines as potential antimalarial agents.
    Ashton WT; Hynes JB
    J Med Chem; 1973 Nov; 16(11):1233-7. PubMed ID: 4583883
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantitative structure-activity relationships of antimalarial and dihydrofolate reductase inhibition by quinazolines and 5-substituted benzyl-2,4-diaminopyrimidines.
    Hansch C; Fukunaga JY; Jow PY
    J Med Chem; 1977 Jan; 20(1):96-102. PubMed ID: 319234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential antileprotic agents. 3. Inhibition of mycobacterial dihydrofolic reductase by 2,4-diamino-5-methyl-6-alkylquinazolines.
    DeGraw JI; Brown VH; Colwell WT
    J Med Chem; 1974 Jul; 17(7):762-4. PubMed ID: 4209923
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of dihydrofolate reductases by derivatives of 2,4-diaminopyrroloquinazoline.
    McCormack JJ; Allen BA; Ledig KW; Hillcoat BL
    Biochem Pharmacol; 1979 Nov; 28(21):3227-9. PubMed ID: 118761
    [No Abstract]   [Full Text] [Related]  

  • 20. Antifolate and antibacterial activities of 5-substituted 2,4-diaminoquinazolines.
    Harris NV; Smith C; Bowden K
    J Med Chem; 1990 Jan; 33(1):434-44. PubMed ID: 2404122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.